SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust (SLV) is facing intense volatility as the market grapples with a combination of surging bond yields, a stronger dollar, and renewed geopolitical tensions in the Middle East. Community sentiment is deeply fractured, with many traders debating whether this sharp pullback is a temporary liquidity flush driven by institutional profit-taking and option-related pinning, or a structural end to the recent commodity rally.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the FDA's acceptance of their supplemental Biologics License Application (sBLA) for Anktiva in bladder cancer, a major step that has ignited intense community debate over the timeline of the upcoming PDUFA date. Investors are actively discussing the significance of the expansion, the ongoing battle against short positions, and high expectations for upcoming ASCO abstract data that could serve as a broader catalyst for the oncology platform.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is generating significant investor buzz as the community actively debates whether the company's massive power infrastructure and pending hyperscaler deals will spark a major breakout. Market participants are closely watching for a potential short squeeze amid high short interest and speculative positioning ahead of upcoming earnings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is capturing intense market attention as traders position for its highly anticipated earnings, which are being closely watched as a critical bellwether for the broader AI-driven tech rally. The community remains deeply divided between those betting on a blowout report that could reignite risk appetite and skeptics warning of a potential 'sell-the-news' reaction due to elevated volatility and high expectations.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing a surge in investor interest and bullish momentum following optimistic commentary from the CEO regarding survival data from its REGAL Phase 3 clinical trial. The community is actively discussing the potential for an imminent short squeeze and institutional accumulation as they await the pivotal 80th trial event, with many viewing the company's immunotherapy pipeline as a transformative candidate for future valuation.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is currently facing intense downward pressure and hitting 52-week lows, driven by investor unease over leadership changes, weaker-than-expected guidance, and broader concerns regarding consumer discretionary spending. While retail investors remain divided between those viewing the current valuation as an attractive long-term entry point for a market-leading subscription model and those liquidating positions due to the stock's persistent bearish technical trend, the community is actively debating whether the current sell-off is a fundamental repricing or a temporary dip exacerbated by institutional sentiment.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is currently a focal point for investors as persistent inflation concerns and rising Treasury yields drive significant volatility, prompting intense community debate over whether bond prices are nearing a bottom or face further declines due to fiscal and geopolitical pressures. While some market participants express frustration over ongoing bond weakness, others are closely watching for signs of institutional accumulation and potential policy shifts from new Federal Reserve leadership.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is surging as the community celebrates a significant earnings beat and raised guidance that validates its aggressive store expansion strategy. Investors are actively discussing the stock's potential to become the next dominant fast-casual player, frequently drawing comparisons to Chipotle while shrugging off concerns about its high valuation.

Agilysys, Inc. operates as a technology company. It offers innovative software for point-of-sale, payment gateway, reservation and table management, guest offers management, property management, inventory and procurement, analytics, document management, and mobile and wireless solutions and services to the hospitality industry. The firm also serves the gaming industry for both corporate and tribal, hotels resort and cruise, foodservice management, and the restaurant, university, and healthcare sectors. The company was founded in 1963 and is headquartered in Alpharetta, GA.

Agilysys, Inc

Agilysys is seeing intense market activity following a strong earnings beat and positive forward guidance, fueling community debates over whether the stock is a long-term growth play or an overvalued target for a correction. Traders are actively monitoring the stock's price action as it attempts to sustain momentum, with many users weighing in on the recent gap-up and the sustainability of the current rally.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending as investors aggressively position themselves for a surge in AI infrastructure demand, with strong momentum driven by the company's critical role in high-performance connectivity and data transport within hyperscale data centers. Community members are actively debating the company's valuation and the long-term potential of its silicon and software solutions as the market shifts focus toward managing the infrastructure bottlenecks inherent in large-scale AI cluster scaling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
